APA (7th ed.) Citation

LS, L., B, O., F, M., RJ, B., L, C., RP, E., & S, T. (2022). Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer? Gynecologic oncology, 165(1), 60. https://doi.org/10.1016/j.ygyno.2022.01.022

Chicago Style (17th ed.) Citation

LS, Lemon, Orr B, Modugno F, Buckanovich RJ, Coffman L, Edwards RP, and Taylor S. "Metformin and Survival: Is There Benefit in a Cohort Limited to Diabetic Women with Endometrial, Breast, or Ovarian Cancer?" Gynecologic Oncology 165, no. 1 (2022): 60. https://doi.org/10.1016/j.ygyno.2022.01.022.

MLA (9th ed.) Citation

LS, Lemon, et al. "Metformin and Survival: Is There Benefit in a Cohort Limited to Diabetic Women with Endometrial, Breast, or Ovarian Cancer?" Gynecologic Oncology, vol. 165, no. 1, 2022, p. 60, https://doi.org/10.1016/j.ygyno.2022.01.022.